Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
Hercules Capital entered a $100 million loan facility with Lexicon Pharmaceuticals to support upcoming regulatory and commercial milestones, replacing an existing facility with Oxford Finance. The agreement provides an initial $55 million tranche, with an additional $45 million available in two tranches subject to clinical milestones and lender consent.
Key figures
- Deal Value Usd
- 100000000
- Maturity date
- May 4, 2030
- Tranche 2 usd
- 20000000
- Initial tranche usd
- 55000000
- Interest rate floor percent
- 9.85
- Interest rate spread percent
- 3.1
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.